• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2002 年和 2006 年比利时巨细胞病毒感染的血清流行率:与甲型肝炎病毒血清流行率的比较分析。

The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: a comparative analysis with hepatitis A virus seroprevalence.

机构信息

Department of Virology,Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University,Merelbeke,Belgium.

Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University,Diepenbeek,Belgium.

出版信息

Epidemiol Infect. 2019 Jan;147:e154. doi: 10.1017/S0950268819000487.

DOI:10.1017/S0950268819000487
PMID:31063104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6518518/
Abstract

Cytomegalovirus (CMV) infection is endemic worldwide but its seroprevalence varies widely. The goal of this study was to estimate the age-specific seroprevalence of CMV infection in Belgium based on two cross-sectional serological datasets from 2002 and 2006. The seroprevalence was estimated relying on diagnostic test results based on cut-off values pre-specified by the manufacturers of the tests as well as relying on mixture models applied to continuous pathogen-specific immunoglobulin G antibody titre concentrations. The age-specific seroprevalence of hepatitis A virus (HAV), based on three Belgian cross-sectional serological datasets from 1993, 2002 and 2006, was used as a comparator since individuals acquire lifelong immunity upon recovery, implying an increasing seroprevalence with age. The age group weighted overall CMV seroprevalence derived from the mixture model was 32% (95% confidence interval (CI) 31-34%) in 2002 and 31% (95% CI 30-32%) in 2006. We demonstrated that CMV epidemiology differs from the immunizing infection HAV. This was the first large-scale study of CMV and HAV serial datasets in Belgium, estimating seroprevalence specified by age and birth cohort.

摘要

巨细胞病毒(CMV)感染在全球范围内流行,但血清流行率差异很大。本研究的目的是根据 2002 年和 2006 年的两项横断面血清学数据集,估计比利时特定年龄组巨细胞病毒感染的血清流行率。血清流行率是根据制造商预先指定的检测截止值的检测结果来估计的,也依赖于应用于连续病原体特异性免疫球蛋白 G 抗体浓度的混合模型。根据 1993 年、2002 年和 2006 年的三项比利时横断面血清学数据集,使用甲型肝炎病毒(HAV)的年龄特异性血清流行率作为比较,因为个体在恢复后获得终身免疫力,这意味着血清流行率随着年龄的增长而增加。混合模型得出的年龄组加权总体 CMV 血清流行率在 2002 年为 32%(95%置信区间[CI]31-34%),在 2006 年为 31%(95% CI 30-32%)。我们证明了 CMV 流行病学与免疫性感染 HAV 不同。这是在比利时进行的首次关于 CMV 和 HAV 系列数据集的大规模研究,估计了按年龄和出生队列指定的血清流行率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/6518518/9ffc12b55c44/S0950268819000487_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/6518518/af1ec079ec38/S0950268819000487_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/6518518/1f2b63332706/S0950268819000487_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/6518518/a37a973666b7/S0950268819000487_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/6518518/34a51553c86f/S0950268819000487_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/6518518/9ffc12b55c44/S0950268819000487_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/6518518/af1ec079ec38/S0950268819000487_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/6518518/1f2b63332706/S0950268819000487_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/6518518/a37a973666b7/S0950268819000487_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/6518518/34a51553c86f/S0950268819000487_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/6518518/9ffc12b55c44/S0950268819000487_fig5.jpg

相似文献

1
The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: a comparative analysis with hepatitis A virus seroprevalence.2002 年和 2006 年比利时巨细胞病毒感染的血清流行率:与甲型肝炎病毒血清流行率的比较分析。
Epidemiol Infect. 2019 Jan;147:e154. doi: 10.1017/S0950268819000487.
2
Is there a change in cytomegalovirus seroepidemiology in Spain?西班牙巨细胞病毒血清流行病学有变化吗?
Eur J Epidemiol. 2004;19(1):85-9. doi: 10.1023/b:ejep.0000013253.56343.6f.
3
[Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].[基于人群的横断面研究对安塔利亚巨细胞病毒血清流行病学的调查及土耳其相关数据综述]
Mikrobiyol Bul. 2007 Oct;41(4):545-55.
4
Seroprevalence to cytomegalovirus in the Portuguese population, 2002-2003.2002-2003 年葡萄牙人群巨细胞病毒血清流行率。
Euro Surveill. 2011 Jun 23;16(25):19896.
5
Seroepidemiology of cytomegalovirus infections in Croatia.克罗地亚巨细胞病毒感染的血清流行病学
Wien Klin Wochenschr. 2017 Feb;129(3-4):129-135. doi: 10.1007/s00508-016-1069-7. Epub 2016 Sep 6.
6
Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.匈牙利实体器官捐献者中巨细胞病毒血清阳性率:与年龄、性别和血型的相关性
Transplant Proc. 2011 May;43(4):1233-5. doi: 10.1016/j.transproceed.2011.03.067.
7
Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications.荷兰的巨细胞病毒感染:血清流行率、危险因素和影响。
J Clin Virol. 2015 Feb;63:53-8. doi: 10.1016/j.jcv.2014.11.033. Epub 2014 Dec 2.
8
Seroprevalence of hepatitis A virus infection among schoolchildren and adolescents in Kaduna, Nigeria.尼日利亚卡杜纳州学童和青少年甲型肝炎病毒感染的血清流行率。
Trans R Soc Trop Med Hyg. 2013 Oct;107(10):627-30. doi: 10.1093/trstmh/trt072. Epub 2013 Aug 19.
9
Changes in cytomegalovirus seroprevalence in pregnant Japanese women-a 10-year single center study.日本孕妇巨细胞病毒血清阳性率的变化——一项 10 年单中心研究。
J Clin Virol. 2014 Mar;59(3):192-4. doi: 10.1016/j.jcv.2013.12.013. Epub 2014 Jan 8.
10
Hepatitis A Virus in Lao People's Democratic Republic: Seroprevalence and Risk Factors.老挝人民民主共和国的甲型肝炎病毒:血清流行率和危险因素。
Am J Trop Med Hyg. 2020 Jul;103(1):164-168. doi: 10.4269/ajtmh.19-0451. Epub 2020 Apr 23.

引用本文的文献

1
Serial Monitoring and Hyperimmunoglobulin versus Standard of Care to Prevent Congenital Cytomegalovirus Infection: A Phase III Randomized Trial.序贯监测与高免疫球蛋白预防先天性巨细胞病毒感染的对比:一项 III 期随机试验。
Fetal Diagn Ther. 2021;48(8):611-623. doi: 10.1159/000518508. Epub 2021 Sep 21.

本文引用的文献

1
Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis.估算全球巨细胞病毒的血清流行率:系统综述和荟萃分析。
Rev Med Virol. 2019 May;29(3):e2034. doi: 10.1002/rmv.2034. Epub 2019 Jan 31.
2
Infectious reactivation of cytomegalovirus explaining age- and sex-specific patterns of seroprevalence.巨细胞病毒的感染再激活解释了血清阳性率的年龄和性别特异性模式。
PLoS Comput Biol. 2017 Sep 26;13(9):e1005719. doi: 10.1371/journal.pcbi.1005719. eCollection 2017 Sep.
3
Public Health Impact of Congenital Toxoplasmosis and Cytomegalovirus Infection in Belgium, 2013: A Systematic Review and Data Synthesis.
先天性弓形虫病和巨细胞病毒感染对 2013 年比利时公共卫生的影响:系统评价和数据综合
Clin Infect Dis. 2017 Aug 15;65(4):661-668. doi: 10.1093/cid/cix344.
4
Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy.先天性巨细胞病毒感染的孕妇和新生儿:预防、诊断和治疗的共识建议。
Lancet Infect Dis. 2017 Jun;17(6):e177-e188. doi: 10.1016/S1473-3099(17)30143-3. Epub 2017 Mar 11.
5
Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions.接种两剂Havrix(甲型肝炎灭活疫苗)后的长期抗体持久性:20年观察数据及基于模型的长期预测
Vaccine. 2015 Oct 13;33(42):5723-5727. doi: 10.1016/j.vaccine.2015.07.008. Epub 2015 Jul 16.
6
Living on three time scales: the dynamics of plasma cell and antibody populations illustrated for hepatitis a virus.生活在三个时间尺度上:甲型肝炎病毒的浆细胞和抗体群体动态。
PLoS Comput Biol. 2012;8(3):e1002418. doi: 10.1371/journal.pcbi.1002418. Epub 2012 Mar 1.
7
Comparative hepatitis A seroepidemiology in 10 European countries.10 个欧洲国家甲型肝炎血清流行病学比较。
Epidemiol Infect. 2012 Dec;140(12):2172-81. doi: 10.1017/S0950268812000015. Epub 2012 Jan 25.
8
Focus on diagnosis: congenital infections (TORCH).关注诊断:先天性感染(TORCH)。
Pediatr Rev. 2011 Dec;32(12):537-42. doi: 10.1542/pir.32-12-537.
9
Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19.模型结构分析估计细小病毒 B19 的基本免疫过程和母体风险。
Biostatistics. 2011 Apr;12(2):283-302. doi: 10.1093/biostatistics/kxq059. Epub 2010 Sep 14.
10
Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.我们是否达到了免疫目标?2006 年比利时特定年龄组麻疹、腮腺炎、风疹、白喉和破伤风的血清抗体阳性率。
Epidemiol Infect. 2011 Apr;139(4):494-504. doi: 10.1017/S0950268810001536. Epub 2010 Jun 29.